Published in J Cancer on April 09, 2017
Cancer-related inflammation. Nature (2008) 34.21
Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol (2001) 11.35
CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol (2003) 9.13
Inflammation and necrosis promote tumour growth. Nat Rev Immunol (2004) 3.68
The therapeutic promise of the cancer stem cell concept. J Clin Invest (2010) 3.26
Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population. Mol Cell (2012) 2.34
IL-6 involvement in epithelial cancers. J Clin Invest (2007) 2.29
Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses. Cancer Res (2012) 2.24
Cytokines in cancer immunity and immunotherapy. Immunol Rev (2004) 2.09
IL-6 expression regulates tumorigenicity and correlates with prognosis in bladder cancer. PLoS One (2013) 1.62
Trimodality treatment and selective organ preservation for bladder cancer. J Clin Oncol (2006) 1.61
Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signaling pathway. Stem Cells (2013) 1.33
Cancer stem cells in bladder cancer: a revisited and evolving concept. Curr Opin Urol (2010) 1.23
Cancer stem cells and radioresistance. Int J Radiat Biol (2014) 1.20
Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cells. Endocr Relat Cancer (2010) 1.18
CD44+/CD24- phenotype contributes to malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma. J Exp Clin Cancer Res (2012) 1.14
Cancer stem cells at the crossroads of current cancer therapy failures--radiation oncology perspective. Semin Cancer Biol (2010) 1.12
Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head-neck cancer. Br J Cancer (2012) 1.07
Suppression of CD44 expression decreases migration and invasion of human glioma cells. Int J Cancer (1996) 1.02
IL-6-stimulated CD11b+ CD14+ HLA-DR- myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus. Oncotarget (2014) 0.98
Combretastatin A-4 inhibits cell growth and metastasis in bladder cancer cells and retards tumour growth in a murine orthotopic bladder tumour model. Br J Pharmacol (2010) 0.97
Enrichment of cancer stem cells based on heterogeneity of invasiveness. Stem Cell Rev (2008) 0.95
Inflammatory pathways as promising targets to increase chemotherapy response in bladder cancer. Mediators Inflamm (2012) 0.91
DNMT1-dependent suppression of microRNA424 regulates tumor progression in human bladder cancer. Oncotarget (2015) 0.89
Stem cells in the biology of normal urothelium and urothelial carcinoma. Neoplasma (2012) 0.89
Intratumoral heterogeneity of DNA indexes in transitional cell bladder cancer: relation to tumor histology. Eur Urol (1991) 0.89
Cancer stem cells and signaling pathways in radioresistance. Oncotarget (2016) 0.87
Non-invasive detection of bladder cancer by identification of abnormal CD44 proteins in exfoliated cancer cells in urine. Clin Mol Pathol (1995) 0.87
Comparison of growth of human bladder cancer in tissue culture or as xenografts with clinical and pathological characteristics. Cancer Res (1984) 0.85
The intersection of cancer, cancer stem cells, and the immune system: therapeutic opportunities. Neuro Oncol (2015) 0.84
CD44 is associated with tumor recurrence and is an independent poor prognostic factor for patients with localized clear cell renal cell carcinoma after nephrectomy. Exp Ther Med (2012) 0.84
Functional and molecular characterization of cancer stem-like cells in bladder cancer: a potential signature for muscle-invasive tumors. Oncotarget (2015) 0.83
In vitro chemosensitivity of J-82 human bladder cancer cells. Urol Res (1986) 0.81
Gamma histone 2AX (γ-H2AX)as a predictive tool in radiation oncology. Biomarkers (2014) 0.81
Breast cancer stem cells and the immune system: promotion, evasion and therapy. J Mammary Gland Biol Neoplasia (2014) 0.81
The role of PD-L1 in the radiation response and clinical outcome for bladder cancer. Sci Rep (2016) 0.81
Updated results of bladder-sparing trimodality approach for invasive bladder cancer. Urol Oncol (2009) 0.80
Hypoxia-inducible proteins HIF1α and lactate dehydrogenase LDH5, key markers of anaerobic metabolism, relate with stem cell markers and poor post-radiotherapy outcome in bladder cancer. Int J Radiat Biol (2016) 0.78
At the Crossroads of Cancer Stem Cells, Radiation Biology, and Radiation Oncology. Cancer Res (2016) 0.77